Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG-Reference-Cited by-同舟云学术

Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG

Published:2021-08-16 Issue:20 Volume:8 Page:2102555
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Shao Jingwei¹,Yan Yuqian²,Ding Donglin²,Wang Dejie²,He Yundong²,Pan Yunqian²,Yan Wei¹,Kharbanda Anupreet¹,Li Hong‐yu¹,Huang Haojie²³⁴^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences College of Pharmacy University of Arkansas for Medical Sciences Little Rock AR 72205 USA

2. Department of Biochemistry and Molecular Biology Mayo Clinic College of Medicine and Science Rochester MN 55905 USA

3. Department of Urology Mayo Clinic College of Medicine and Science Rochester MN 55905 USA

4. Mayo Clinic Cancer Center Mayo Clinic College of Medicine and Science Rochester MN 55905 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202102555

Reference40 articles.

1. Targeting Transcription Factors for Cancer Treatment

2. Targeting transcription factors by small compounds—Current strategies and future implications

3. Targeted protein degradation: elements of PROTAC design

4. Targeted protein degraders crowd into the clinic

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted protein degradation: current molecular targets, localization, and strategies;Drug Discovery Today;2024-09

2. Engineering artificial non-coding RNAs for targeted protein degradation;Nature Chemical Biology;2024-08-30

3. Small-Molecule Approaches to Target Transcription Factors;Annual Review of Cancer Biology;2024-06-12

4. Expanding the horizons of targeted protein degradation: A non-small molecule perspective;Acta Pharmaceutica Sinica B;2024-06

5. Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein;Advanced Science;2024-04-29